We’re excited to share that Cairn Diagnostics will attend the 85th Scientific Sessions of the American Diabetes Association (ADA), which will take place June 20–23, 2025, at the McCormick Place Convention Center in Chicago. This world-renowned event brings together the brightest minds in diabetes research, care, and innovation, and we’re proud to be a part of it.
As leaders in non-invasive diagnostic testing, our team at Cairn Diagnostics is committed to improving outcomes for individuals with diabetes, especially those facing complications like gastroparesis. The 85th Scientific Sessions presents a powerful opportunity for connection, collaboration, and continued advancement in this critical field.
Key Highlights for the 85th Scientific Sessions
- Cairn Diagnostics is attending ADA’s 85th Scientific Sessions to advance care for diabetic gastroparesis.
- GEBT offers a non-invasive, FDA-approved test for delayed gastric emptying.
- Scientific Sessions is a chance to connect, collaborate, and drive innovation in diabetes care.
About ADA’s 85th Scientific Sessions
Now in its 85th year, the ADA Scientific Sessions is the largest diabetes-focused meeting in the world. With over 180 sessions and more than 2,000 original research presentations, the conference is a cornerstone for medical professionals, researchers, and industry experts to share knowledge, explore innovation, and shape the future of diabetes care.
From cutting-edge treatment developments to dynamic networking and the ADA’s Innovation Challenge for emerging solutions, this event is a hub for progress and a perfect space for companies like Cairn Diagnostics to support meaningful change.
Why We’re Attending
Gastroparesis is a frequent, often underdiagnosed complication of diabetes. It disrupts gastric motility, making digestion unpredictable and blood glucose management more difficult. At Cairn Diagnostics, we’ve developed the Gastric Emptying Breath Test (GEBT), an FDA-approved, non-invasive diagnostic tool that provides a practical, accurate alternative to traditional gastric emptying studies.
Our GEBT enables healthcare providers to assess delayed gastric emptying efficiently, in clinical settings and remotely through telehealth programs. With no radiation, no invasive equipment, and simple at-home options, GEBT is designed with the patient in mind.
Attending the Scientific Sessions allows us to share how GEBT supports earlier diagnosis, better care pathways, and improved outcomes for individuals with diabetes and suspected gastroparesis.
Advancing Digestive Health in Diabetes Care
For patients with diabetes, gastroparesis impacts more than digestion. It influences blood sugar stability, medication absorption, and overall quality of life. Recognizing and diagnosing this condition is essential for personalized diabetes care and long-term management.
Through innovation and a patient-first approach, Cairn Diagnostics is focused on empowering healthcare providers with better tools to detect and address this challenging complication.
Let’s Connect at Scientific Sessions
We look forward to meeting fellow healthcare professionals, researchers, and industry partners at the 85th Scientific Sessions this June. Whether you’re attending to explore the latest in diabetes innovation, find diagnostic solutions to enhance your practice, or simply learn more about our work at Cairn Diagnostics, we’d love to connect.
If you’re interested in discussing how GEBT can support your clinical goals or want to hear more about our approach to digestive health in diabetes, contact us to schedule a conversation. Let’s work together to advance diagnostics.
